QQQ   425.76 (-0.02%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)
QQQ   425.76 (-0.02%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)
QQQ   425.76 (-0.02%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)
QQQ   425.76 (-0.02%)
AAPL   167.88 (-0.07%)
MSFT   408.36 (-0.84%)
META   506.07 (+2.41%)
GOOGL   155.94 (+0.30%)
AMZN   181.21 (-0.04%)
TSLA   150.48 (-3.20%)
NVDA   845.83 (+0.65%)
AMD   154.69 (+0.44%)
NIO   3.99 (+2.05%)
BABA   69.24 (+0.61%)
T   16.16 (+0.25%)
F   12.09 (+0.42%)
MU   116.92 (+0.51%)
GE   157.72 (+1.32%)
CGC   7.06 (+8.78%)
DIS   113.39 (+0.40%)
AMC   2.79 (-6.38%)
PFE   25.35 (-0.28%)
PYPL   63.07 (-0.30%)
XOM   119.05 (+0.35%)

Veracyte (VCYT) Stock Forecast & Price Target

$19.06
+0.20 (+1.06%)
(As of 10:22 AM ET)

Veracyte Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 5 Analyst Ratings

Analysts' Consensus Price Target

$29.00
52.15% Upside
High Forecast$34.00
Average Forecast$29.00
Low Forecast$21.00
TypeCurrent Forecast
4/19/23 to 4/18/24
1 Month Ago
3/20/23 to 3/19/24
3 Months Ago
1/19/23 to 1/19/24
1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$29.00$30.00$29.50$30.20
Predicted Upside52.15% Upside31.87% Upside33.14% Upside30.53% Upside
Get Veracyte Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter.

VCYT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VCYT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Veracyte Stock vs. The Competition

TypeVeracyteMedical CompaniesS&P 500
Consensus Rating Score
2.60
2.68
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside53.76% Upside934.34% Upside12.27% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/15/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$32.00 ➝ $28.00+41.34%
2/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$22.00 ➝ $21.00-10.18%
2/23/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
2/23/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$30.00 ➝ $33.00+35.58%
10/10/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$34.00+51.52%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 10:41 AM ET.

VCYT Price Target - Frequently Asked Questions

What is Veracyte's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Veracyte stock is Moderate Buy based on the current 1 sell rating and 4 buy ratings for VCYT. The average twelve-month price prediction for Veracyte is $29.00 with a high price target of $34.00 and a low price target of $21.00. Learn more on VCYT's analyst rating history.

Do Wall Street analysts like Veracyte more than its competitors?

Analysts like Veracyte less than other Medical companies. The consensus rating score for Veracyte is 2.60 while the average consensus rating score for medical companies is 2.68. Learn more on how VCYT compares to other companies.

Does Veracyte's stock price have much upside?

According to analysts, Veracyte's stock has a predicted upside of 28.93% based on their 12-month stock forecasts.

What analysts cover Veracyte?

Veracyte has been rated by Morgan Stanley, Needham & Company LLC, The Goldman Sachs Group, and William Blair in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:VCYT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners